Puma Biotechnology | Creditori Commerciali



Trade Creditors Cambiamento Data
Agios Pharmaceuticals USD 13.73M 2.92M 2025-03
Alnylam Pharmaceuticals USD 97.4M 8.98M 2025-03
Amgen USD 2.41B 498M 2025-03
Biogen USD 391.5M 32.7M 2025-03
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Daiichi Sankyo JPY 564.47B 61.64B 2024-12
Exelixis USD 42.84M 4.65M 2025-04
Gilead Sciences USD 833M 70M 2024-12
Glaxosmithkline 3.46B 10.01B 2024-12
Incyte USD 195.54M 1.93M 2025-03
MacroGenics USD 5.01M 1.6M 2024-12
Moderna USD 226M 179M 2025-03
Novartis USD 4.57B 485M 2024-12
Pfizer USD 5.24B 393M 2025-03
PTC Therapeutics USD 15.15M 2.12M 2025-03
Regeneron Pharmaceuticals USD 705.5M 4.18B 2025-03
Roche Holding 4.35B 828M 2024-12
Sarepta Therapeutics USD 156.1M 58.34M 2025-03
Takeda JPY 475.54B 15.36B 2025-03
TG Therapeutics 41.97M 34.78M 2024-09
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12


Puma Biotechnology Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.